SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Hippieslayer who wrote (18711)4/6/1998 4:39:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
FUGAZI, Phen/fen heart valve damage was real. The AHP study was for the lawyers, not the patients. Redux will not be on the market again.

The breast cancer prevention study was for patients at high risk for developing breast cancer and even among this high risk group, twice as many patients had blood clots on their lungs than those who didn't get breast cancer because of the treatment.